Calcium-Regulating Hormones and Agents Market
Number of pages: 100 | Report Format: PDF | Published date: May 16, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
CAGR |
4.46% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Types, Route of Administration, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global calcium-regulation hormones market is expected to register a revenue CAGR of 4.46% during the forecast period from 2023 to 2031.
Calcium-Regulating Hormones and Agents Market Fundamentals
Calcium-regulating hormones and agents are substances that play a crucial role in maintaining calcium homeostasis in the body. These hormones and agents play a crucial role in regulating calcium levels in the blood and tissues, ensuring the proper functioning of various physiological processes. Some examples of calcium-regulating hormones and agents such as calcitonin, vitamin D, calcitriol, calcimimetics, bisphosphonates, and estrogen. These hormones and agents work together to maintain the delicate balance of calcium in the body. They are essential in bone health, nerve transmission, muscle function, and other physiological processes.
The research study on the calcium-regulating hormones and agents market overview thoroughly analyzes the market and the aspects that either help or hinder the market's growth, such as its drivers, challenges, and opportunities. The research also discusses the list of businesses that operate in this market and their efforts to establish themselves as significant players through expansion plans and innovative ideas. It also emphasizes current events that support the market's revenue expansion.
This report is an important tool for the industry stakeholders to gather all the information about the market, customers, and competition. The report also provides the readers with valuable insights on the segmentation, regions, market size & forecast, revenue CAGRs, and other useful data to help make strategic decisions. The study compiles information gathered from industry participants and specialists across the industry value chain. The report also taps into the qualitative and quantitative assessments by industry analysts. Our reports use different methods for estimating the market size and forecast, including secondary research, surveys and interviews, and statistical modeling. With these steps, our reports provide the most accurate market data. These datasets will cumulatively provide an in-depth calcium-regulating hormones and agents market forecast to the industry stakeholders.
Calcium-Regulating Hormones and Agents Market Dynamics
The prevalence of calcium-related disorders such as osteoporosis, hyperparathyroidism, and hypocalcemia are on the rise globally. According to WHO studies on osteoporosis, nearly 6.3% of men and 21.2% of women in the age group above 50 have osteoporosis, which is almost 500 million people across the globe are likely to be affected by this disease. These conditions necessitate calcium-regulating hormones and agents for diagnosis, treatment, and management, thereby driving the market growth. The aging population significantly drives the calcium-regulating hormones and agents market. According to a 2023 article published by “Age International,” approximately 962 million people are estimated to be over 60. As agents duals age, the risk of calcium-related disorders and bone diseases, such as osteoporosis, increases. This demographic shift fuels the demand for calcium-regulating hormones and agents for therapeutic purposes. Individuals are growing aware of the importance of bone health and the prevention of calcium-related disorders. This increased awareness leads to early diagnosis and treatment, driving the demand for calcium-regulating hormones and agents.
Furthermore, the growing technological advancements in diagnostic tools, such as bone densitometry and biochemical assays, have facilitated early detection and monitoring of calcium-related disorders. This has increased the demand for calcium-regulating hormones and agents as part of comprehensive treatment strategies. Rising healthcare expenditure, particularly in developing countries, positively impacts the calcium-regulating hormones and agents market. Moreover, increased investment in healthcare infrastructure, improved access to healthcare services, and reimbursement policies contribute to market growth. Changing lifestyles, including sedentary behavior and unhealthy dietary habits, increase the prevalence of calcium-related disorders. This further drives the demand for calcium-regulating hormones and agents to address health issues. The calcium-regulating hormones and agents market is also magnetizing significant growth in emerging markets due to improving healthcare infrastructure, rising disposable incomes, and increasing awareness about calcium-related disorders. These regions offer untapped opportunities for market players to expand their presence.
Calcium-Regulating Hormones and Agents Market Ecosystem
Calcium-Regulating Hormones and Agents Market, Types
Calcium-Regulating Hormones and Agents Market, by Route of Administration
Calcium-Regulating Hormones and Agents Market by Route of Administration
[56546]
The oral segment accounts for the largest global calcium-regulating hormones and agents market revenue share. Oral administration is the most common and convenient route of drug administration for patients. The oral segment offers various calcium-regulating hormones and agents in various formulations. This includes oral bisphosphonates, vitamin D supplements, and other oral agents used to treat calcium-related disorders. The availability of different oral products provides healthcare professionals with options to tailor treatment plans to individual patient needs. The oral route allows patients to self-administer medications without needing healthcare professionals, especially in chronic conditions like osteoporosis. This self-administration potential enhances patient autonomy and convenience and reduces healthcare costs associated with hospital visits or injections.
Additionally, the familiarity and acceptance of oral drugs among healthcare professionals and patients contribute to the dominance of this segment. Oral medications are often considered cost-effective compared to other routes of administration, such as injectables or intravenous formulations. Oral drug production, packaging, and distribution costs are generally lower, making them more affordable for patients and healthcare systems. This cost-effectiveness further drives the market demand for oral calcium-regulating hormones and agents. Many patients prefer oral medications due to convenience, ease of administration, and the perception of lower invasiveness compared to injections or other routes. Patient preference plays a significant role in driving the demand for oral formulations, thereby contributing to the larger revenue share of the oral segment.
Segmentation of the market refers to the division of the industry into subgroups based on factors such as type, route of administration, etc. Market segmentation data helps businesses to understand the preferences and unique needs of different customer groups and develop targeted sales strategies. This information also helps in identifying potential muscarinic agonist market growth opportunities.
Calcium-Regulating Hormones and Agents Market by Region
Based on region, the global calcium-regulating hormones and agents market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America has a well-developed and advanced healthcare infrastructure. The region is home to leading pharmaceutical companies, research institutions, and academic centers that are at the forefront of calcium regulation research and development. The availability of state-of-the-art healthcare facilities and expertise contributes to the dominance of the market in North America. North America has a high prevalence of calcium-related disorders such as osteoporosis, hypocalcemia, and hyperparathyroidism. These conditions necessitate calcium-regulated hormones and agents for diagnosis, treatment, and management. The larger patient pool and the associated demand for medications contribute to the dominance of the market in the region. The region is known for its technological advancements in healthcare, including diagnostic tools and therapeutic interventions. Technological innovations facilitate early detection, accurate diagnosis, and monitoring of calcium-related disorders, driving the demand for calcium-regulating hormones and agents.
Moreover, North America has a robust research and development ecosystem in the pharmaceutical and biotechnology sectors. The region invests significantly in research, clinical trials, and drug development, resulting in the introduction of innovative calcium-regulating hormones and agents. The presence of key industry players and academic institutions conducting cutting-edge research further strengthens market dominance. This facilitates market growth and dominance in the region. The aging population in North America is increasing, leading to a higher prevalence of calcium-related disorders such as osteoporosis. As individuals age, the risk of these conditions and the need for calcium-regulating hormones and agents also increase. The larger population of older adults in North America contributes to the dominance of the market. North America has a competitive pharmaceutical market, with significant market players and pharmaceutical companies specializing in developing and commercializing calcium-regulated hormones and agents. The region attracts investments, fosters innovation, and contributes to the dominance of the market.
Based on the regions, the global calcium-regulating hormones and agents market is segmented into:
Regional demarcation of the industry will provide information on geographic pockets regarding calcium-regulating hormones and agents market outlook, size, share, and growth rate. This data helps businesses evaluate the expansion potential into new regional markets, understand the competitive threats across different regions, and develop localized sales and expansion strategies.
Competitive Landscape
The prominent players operating in the calcium-regulating hormones and agents market are:
Key Strengths of Our Report
Target Audience to Benefit from this Report.
Reasons to Buy this Report
Calcium-regulating hormones and agents are substances that play a crucial role in maintaining calcium homeostasis in the body. These hormones and agents help regulate calcium levels in the blood and tissues, ensuring the proper functioning of various physiological processes.
North America has the largest global calcium-regulating hormones and agents market revenue share.
The global calcium-regulating hormones and agents market is estimated to grow at a revenue CAGR of 4.46% from 2023 to 2031
Increasing adoption of lifestyle changes and sedentary behavior, aging population growth, and awareness of bone health are prominent trends in global muscarinic agonists.
Emerging markets and growing public awareness are major global calcium-regulating hormones and agents market opportunities.
Side effects, safety concerns, patent expirations, and generic competition are the major restraining factors hamper the overall market growth.
Pfizer Inc., Novartis AG, Eli Lilly and Company, and Zydus Lifesciences Limited calcium-regulating hormones and agents are some of the major market players in the global calcium-regulating hormones and agents market.
The oral administration of drugs accounts for a significant revenue share in the global market.
The oral administration of drugs accounts for a significant revenue share in the global market.
*Insights on financial performance are subject to the availability of information in the public domain